Genentech and Novartis (Xolair/Omalizumab) on Two Ts In A Pod with Teddi Mellencamp and Tamra Judge
Dirty Rush: MORE Sex Lives of Sorority Girls
Transcript
Xolair omalizumab is proven to significantly reduce allergic reactions if a food allergy accident happens. Xolair 150 mg is a prescription medication used to treat food allergy in people one year of age and older to reduce allergic reactions due to accidental exposure to one or more foods. While taking Xolair, you should continue to avoid all foods to which you are allergic. Don't use if you are allergic to Xolair. Xolair may cause a severe, life-threatening allergic reaction called anaphylaxis. Tell your doctor if you ever had anaphylaxis. Get help right away if you have trouble breathing or if you have swelling of your throat or tongue. Xolair should not be used for the emergency treatment of allergic reactions, including anaphylaxis. Xolair is for maintenance use to reduce allergic reactions, including anaphylaxis, while avoiding food allergens. Serious side effects such as cancer, fever, muscle aches, and rash, parasitic infection, or heart and circulation problems have been reported. Please see Xolair.com for full prescribing information. Ask an allergist about Xolair. This is an advertisement for Xolair paid for by Genentech and Novartis.
Estimated ad cost
Estimate of what a similar one-episode podcast ad would cost based on rank, placement, and duration
Methodology and limitations →Genentech and Novartis (Xolair/Omalizumab) sponsor landing page on Two Ts In A Pod with Teddi Mellencamp and Tamra Judge
Genentech and Novartis (Xolair/Omalizumab) landing page captured for its sponsorship on Two Ts In A Pod with Teddi Mellencamp and Tamra Judge.

